Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality
J. Clin. Invest. Majed N. Aljamali, et al. 118:1825
doi:10.1172/JCI32878 [Go to this article.]

Figure 3
In vivo tests of coagulation. (A) Blood loss in mFVIIa transgenic HB mice expressing low (HB-Low mFVIIa, n = 10) or high (HB-High mFVIIa, n = 8) levels of mFVIIa, compared with HB (n = 20) and WT (n = 10) littermates. *P < 0.05 versus HB. Values are mean ± 1 SD. (B) Representative cremaster real-time thrombus formation in WT, HB, or HB-mFVIIa (high and low expresser) mice. (C) FeCl3 carotid artery injury in WT, HB, or HB-mFVIIa (high and low expresser) mice. The single asterisk denotes the time at which the FeCl3 patch was applied; the double asterisk denotes vessel occlusion. Results are from 1 indicative mouse per group.